Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

N/ACompletedNCT00163631

Bayside Health

Overview

Investigate vasoactive medicators in portal hypertension on stored sera

Study Type

OBSERVATIONAL

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * portal hypertension Exclusion Criteria: * Nil

Alfred Hospital

Melbourne, Victoria, Australia

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.